Lorena de la Fuente Selected Research

Inborn Genetic Diseases (Disease, Hereditary)

1/2022

An evaluation of pipelines for DNA variant detection can guide a reanalysis protocol to increase the diagnostic ratio of genetic diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorena de la Fuente Research Topics

Disease

2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Insulin Resistance 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2021
1	Neoplasms (Cancer) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Osteoarthritis 02/2016
1	Rheumatoid Arthritis 02/2016

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 12/2021 - 02/2016
2	MicroRNAs (MicroRNA)IBA 12/2021 - 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	Trastuzumab (Herceptin)FDA Link 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	pertuzumabIBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 02/2016

Therapy/Procedure

2	Therapeutics 12/2021 - 12/2021